Il-1 Blocking Agents has 2 known drug interactions based on U.S. FDA drug labeling data. 2 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Canakinumab, Rilonacept. Patients taking Il-1 Blocking Agents should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Major
- 2
Major (2)
- Il-1 Blocking Agents + Canakinumab— Concomitant administration with other IL-1 blockers or IL-1 receptor antagonists is not recommended due to potential pha…
- Il-1 Blocking Agents + Rilonacept— Concomitant administration not recommended due to potential for pharmacologic interactions and increased risk of serious…